Consegna Pharma's Innovative Strategy to Combat Opioid Epidemic Gains FDA Support for CP217 Consegna Pharma receives FDA approval for its innovative modeling strategy for CP217, an effective solution to prevent deaths from the opioid epidemic.

Consegna Pharma's Innovative Strategy to Combat Opioid Epidemic Gains FDA Support for CP217 #USA #Pittsburgh #FDA_Guidance #Consegna_Pharma #CP217